BREAKTHROUGH IN HAIR LOSS TREATMENT | UCLA’s Discovery PP405 or UCLA Discovered Breakthrough In Hair Loss Treatment PP405
The problem of hair loss has been very annoying to both men and women and has proven to be difficult to remedy through any means including application of minoxidil, finasteride or even removal through invasive procedures such as transplants. The trichological and regenerative medicine world has its new hope though – a topical drug, PP405, which was produced by Pelage Pharmaceuticals and tested by the UCLA researchers. PP405 has demonstrably worked wonders in the early trials of triggering hair growth in people with androgenetic alopecia (AGA) also known as the most common hair loss type.
The discovery holds a new promise of an era in which hair loss can finally be reversed non-invasively and the problem can be managed and reversed possibly in the future.
How Does PP405 Work?
Men and women developed hair loss as a very aggravating problem, which was quite hard to correct by any means even applying minoxidil and finasteride or even removing the hair using some invasive treatment procedures like transplantation. The trichological and regenerative medicine world has its new hope however, being a topical drug, PP405, manufactured by Pelage Pharmaceuticals that were tested by the researchers of the UCLA. PP405, has proved beyond doubt, to be magic during its initial trials of propagating hair growth in individuals with androgenetic alopecia (AGA) otherwise also referred to, as the most common form of hair loss.
The finding has a new hope of an age when balding can no longer be irreversible and when it is a problem that can be tackled and regained, perhaps in the future.
Why This Matters
- Non-invasive solution for both men and women
- Targets the root cause of hair follicle miniaturization
- No systemic side effects, unlike oral drugs
- Suitable for individuals who cannot undergo PRP or transplant procedures
When Will It Be Available?
PP405 is a clinical trial that is currently being executed further before the FDA approval. It is not commercially available at present, but it can be expected to be in 2-3 years, provided the success of the current trial progresses.
That is why clinics and trichologists should remain informed about the development of such revolutionary treatment.
What This Means for You
The PP405 points to a bright future in case you have a hair loss problem and have not fared too well with available treatments. Although this therapy is yet to be utilized on a commercialized scale, it reinstates the significance of attacking the biochemical mechanisms and processes that contribute to hair loss.
Meanwhile, you may consider such sophisticated options as PRP or Exosome Therapy or GFC treatments that perform the same stimulation on the cellular level. Such doctor-centric clinics as the Revive of Dr. Pankti in Mumbai are already providing non-surgical scientifically-proven solutions to the problem.
Final Thoughts
The finding of PP405 is an epidemiological breakthrough in the way hair loss is treated as treatment aims at the elimination of the root of the problem an not a superficial outcome. Although it is still not commercially rolled out, it proves that there is some movement in the right direction in scientific studies toward employing more efficient, harmless, and convenient solutions.